Matches in Wikidata for { <http://www.wikidata.org/entity/Q74275605> ?p ?o ?g. }
Showing items 1 to 31 of
31
with 100 items per page.
- Q74275605 description "clinical trial" @default.
- Q74275605 description "ensayu clínicu" @default.
- Q74275605 description "klinisch onderzoek" @default.
- Q74275605 description "клінічне випробування" @default.
- Q74275605 name "Phase 1 Trial of LVGN6051 as Single Agent and in Combination Therapy in Advanced or Metastatic Malignancy" @default.
- Q74275605 name "Phase 1 Trial of LVGN6051 as Single Agent and in Combination Therapy in Advanced or Metastatic Malignancy" @default.
- Q74275605 type Item @default.
- Q74275605 label "Phase 1 Trial of LVGN6051 as Single Agent and in Combination Therapy in Advanced or Metastatic Malignancy" @default.
- Q74275605 label "Phase 1 Trial of LVGN6051 as Single Agent and in Combination Therapy in Advanced or Metastatic Malignancy" @default.
- Q74275605 prefLabel "Phase 1 Trial of LVGN6051 as Single Agent and in Combination Therapy in Advanced or Metastatic Malignancy" @default.
- Q74275605 prefLabel "Phase 1 Trial of LVGN6051 as Single Agent and in Combination Therapy in Advanced or Metastatic Malignancy" @default.
- Q74275605 P1132 Q74275605-CA3783A4-E70F-4141-8C39-33EF95C84931 @default.
- Q74275605 P1476 Q74275605-C0DDEF76-8A21-4305-B759-24628ABED4A7 @default.
- Q74275605 P17 Q74275605-DCCEF1A9-E006-4D29-8488-6D754AA80946 @default.
- Q74275605 P2899 Q74275605-4E4E765B-FD4E-49C8-8A85-AA9106AC4B45 @default.
- Q74275605 P3098 Q74275605-B69528CE-D110-49DF-AA4A-1B2A3C14B51E @default.
- Q74275605 P31 Q74275605-6F10650D-23B5-406E-B1B3-BF0365BB3513 @default.
- Q74275605 P580 Q74275605-9D1FD2E7-CF59-4C77-A2E4-54BAF48733DA @default.
- Q74275605 P582 Q74275605-DDA20991-0D88-4BAA-A209-A63F55933639 @default.
- Q74275605 P6099 Q74275605-6848A63B-2DE9-44B6-9753-BB0B199BA77A @default.
- Q74275605 P8363 Q74275605-17717DA8-94DA-4AE4-9609-4DA9BC4CB2F5 @default.
- Q74275605 P1132 "+276" @default.
- Q74275605 P1476 "An Open Label, First in Human (FIH), Phase 1 Trial of LVGN6051 as Single Agent and in Combination With Keytruda (Pembrolizumab) in Advanced or Metastatic Malignancy" @default.
- Q74275605 P17 Q30 @default.
- Q74275605 P2899 "+18" @default.
- Q74275605 P3098 "NCT04130542" @default.
- Q74275605 P31 Q30612 @default.
- Q74275605 P580 "2019-10-31T00:00:00Z" @default.
- Q74275605 P582 "2021-10-01T00:00:00Z" @default.
- Q74275605 P6099 Q5452194 @default.
- Q74275605 P8363 Q78089383 @default.